Zhejiang Dafeng Industry Co., Ltd (SHA:603081)

Regulus Therapeutics Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,395	4,622	5,579	5,105	5,576	4,360
Market Cap Growth	4.95%	-17.15%	9.28%	-8.44%	27.90%	-33.47%
Enterprise Value	6,915	6,598	7,468	6,445	6,192	4,289
Last Close Price	12.77	11.19	13.42	12.17	13.07	10.26
PE Ratio	80.53	71.54	55.24	17.79	14.27	13.90
Forward PE	17.99	15.80	10.54	10.54	13.84	-
PS Ratio	2.93	2.51	2.88	1.80	1.89	1.74
PB Ratio	1.67	1.59	1.90	1.76	2.10	1.88
P/TBV Ratio	1.77	1.70	2.02	1.88	2.26	2.05
P/FCF Ratio	137.22	-	-	-	-	-
P/OCF Ratio	38.08	43.88	33.09	-	-	20.82
EV/Sales Ratio	3.75	3.58	3.85	2.27	2.09	1.71
EV/EBITDA Ratio	111.46	73.13	132.98	17.60	12.57	10.92
EV/EBIT Ratio	-	266.18	-	20.13	13.63	11.98
EV/FCF Ratio	175.87	-	-	-	-	-
Debt / Equity Ratio	0.73	0.94	0.88	0.86	0.79	0.44
Debt / EBITDA Ratio	38.09	28.80	42.38	6.67	4.21	2.59
Debt / FCF Ratio	60.10	-	-	-	-	-
Asset Turnover	0.24	0.23	0.25	0.39	0.48	0.53
Inventory Turnover	4.40	5.03	6.40	7.34	7.37	3.41
Quick Ratio	1.30	1.00	1.15	1.30	1.46	1.59
Current Ratio	1.56	1.15	1.30	1.45	1.62	1.75
Return on Equity (ROE)	2.00%	2.12%	3.30%	10.00%	15.39%	14.29%
Return on Assets (ROA)	-0.08%	0.20%	-0.05%	2.71%	4.63%	4.71%
Return on Capital (ROIC)	-0.11%	0.28%	-0.07%	3.94%	7.01%	7.41%
Return on Capital Employed (ROCE)	-	0.50%	-	6.50%	10.10%	11.50%
Earnings Yield	1.18%	1.40%	1.81%	5.62%	7.01%	7.20%
FCF Yield	0.73%	-0.09%	-1.29%	-15.26%	-10.68%	-7.57%
Dividend Yield	1.03%	1.16%	0.37%	1.23%	1.53%	1.46%
Payout Ratio	214.39%	167.78%	158.40%	58.78%	25.36%	16.13%
Buyback Yield / Dilution	0.73%	0.05%	2.87%	5.29%	-0.81%	0.40%
Total Shareholder Return	1.78%	1.21%	3.24%	6.53%	0.72%	1.86%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.